Prof. Dr. Inge Marie Svane has 25 years of research experience in cancer immunology and immunotherapy, and holds a PhD in basic cancer immunology and a professorship in clinical cancer immunotherapy. She has pioneered the field of cancer immunotherapy in Denmark, building up CCIT, a translational research center with a leading position in Europe. Her focus of expertise is T-cell-based adoptive cell therapy and other cellular therapies, cancer vaccines, and immune regulation. Since 2001, she has initiated 18 phase I, II, and III immunotherapeutic trials as a sponsor. Furthermore, she is a national principal/investigator on numerous international clinical trials in collaboration with the pharmaceutical industry, primarily within the area of immunotherapy. She frequently serves internationally as a reviewer of scientific papers, applications, and awards.